TRPM3 and cyst: A comparison of findings from IBMX-driven cystic kidneys clearly demonstrated that TRPM3 inhibition with isosakuranetin sensitized the kidneys to IBMX-induced cyst formation, increasing both cyst area and number (Fig. S10a,b).